Quick Takeaways
- ABG Management Ltd. filed SCHEDULE 13D/A for ProMIS Neurosciences Inc. Common Shares, no par value per share (PMN).
- Disclosed ownership: 17%.
- Date of event: 03 Feb 2026.
Quoteable Key Fact
"ABG Management Ltd. disclosed 17% ownership in ProMIS Neurosciences Inc. Common Shares, no par value per share (PMN) on 03 Feb 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ABG Management Ltd. | 6.3% | 572,677 | 0 | 572,677 | By: /s/ Fan Yu | Fan Yu, Director | 0001832106 |
| Ally Bridge Group (NY) LLC | 6.3% | 572,677 | 0 | 572,677 | By: ABG Management Ltd., its managing member, By: /s/ Fan Yu | Fan Yu, Director | 0001822947 |
| Ally Bridge MedAlpha Master Fund L.P. | 6.3% | 572,677 | 0 | 572,677 | By: Ally Bridge Group (NY) LLC, its manager, By: ABG Management Ltd., its managing member, By: /s/ Fan Yu | Fan Yu, Director | 0001831963 |
| ABG V-SIV IX Limited | 7.1% | 659,520 | 0 | 659,520 | By: ABG Global Life Science Capital Partners V GP, L.P., ABG Global Life Science Capital Partners V GP Limited, /s/ Fan Yu | Fan Yu, Director | |
| Ally Bridge Group Global Life Science Capital Partners V, L.P. | 7.1% | 659,520 | 0 | 659,520 | By: ABG Global Life Science Capital Partners V GP, L.P., its GP, By: ABG Global Life Science Capital Partners V GP Limited, its GP, By: /s/ Fan Yu | Fan Yu, Director | |
| ABG Global Life Science Capital Partners V GP, L.P. | 7.1% | 659,520 | 0 | 659,520 | By: ABG Global Life Science Capital Partners V GP Limited, its general partner, By: /s/ Fan Yu | Fan Yu, Director | |
| ABG Global Life Science Capital Partners V GP Limited | 7.1% | 659,520 | 0 | 659,520 | By: /s/ Fan Yu | Fan Yu, Director | |
| ABG V-SIV X Limited | 4.5% | 412,200 | 0 | 412,200 | By: /s/ Fan Yu | Fan Yu, Director | |
| Fan Yu | 17% | 1,644,397 | 0 | 1,644,397 | /s/ Fan Yu | Fan Yu | 0001668029 |